Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients.

Alkan, Aylin; Hofving, Tobias; Angenete, Eva; Yrlid, Ulf

Alkan, Aylin; Hofving, Tobias; Angenete, Eva; Yrlid, Ulf.

Afiliación

Alkan A; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Hofving T; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Angenete E; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Yrlid U; Region Västra Götaland, Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Sahlgrenska University Hospital, Gothenburg, Sweden.

Biomark Res ; 9(1): 60, 2021 Jul 28.

Article en En | MEDLINE | ID: mdl-34321074

Palabras clave

Biomarkers; Microenvironment; Neoadjuvant therapy; Patient-derived organoids; Patient-derived xenografts; Rectal cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomark Res Año: 2021 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google